Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2026-06-30 @ 3:11 AM
Study NCT ID:
NCT03871257
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-17
First Post:
2019-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Sponsor:
National Cancer Institute (NCI)
Organization: